retatrutide safety profile clinical trials Retatrutide—A Game Changer in Obesity Pharmacotherapy Is Retatrutide Safe for Women?

these are not specific to vaginal endpoints but support monitoring hydration status

[1] [3] According to the UK SmPC, dosing starts at 2.5 mg once weekly for 4 weeks, then increases in 2.5 mg increments every 4 weeks until the target dose (5 mg, 7.5 mg, 10 mg, 12.5 mg or 15 mg) is reached, based on individual response and tolerability

Improve Sleep Quality Getting 79 hours of quality beauty sleep each night naturally boosts GLP-1 production by aligning your circadian rhythm, enhancing vagus nerve activity, and supporting a healthy gut microbiome that triggers GLP-1 release (St-Onge et al., 2016)

If side effects become intolerable at any dose level, dropping back to the previous dose for two to four additional weeks before attempting escalation again often allows successful progression